Assessment of Coronary Artery Disease by Hybrid PET/CT
Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies
1 other identifier
interventional
30
1 country
1
Brief Summary
There have been many advances in the test used to look for heart disease. An example of this newer technology is the Multislice CT scan (MSCT) and Positron Emission Tomography (PET) scans. The use of this type of combined scan may show early coronary artery disease or the degree of damaged heart muscle form a heart attack with a single exam. It may help doctors to know who might benefit from heart surgery or angioplasty to increase the blood flow to the heart. This type of detailed images has previously been available only through cardiac catheterization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Mar 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 28, 2006
CompletedFirst Posted
Study publicly available on registry
May 3, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedResults Posted
Study results publicly available
June 9, 2021
CompletedJune 9, 2021
May 1, 2021
2.1 years
April 28, 2006
August 20, 2010
May 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Incremental Value of Adenosine Flow Reserve by Rubidium PET to Clinically Acquired Gated Studies.
All data were acquired in list-mode for 8 minutes and retrospectively sorted into static, ECG gated and dynamic images. Rubidium retention was calculated by dividing the late (3-8 minute) whole myocardium region-of-interest data by the integral of the input function over the first minute. Adenosine flow reserve was estimated by dividing rubidium retention during adenosine vasodilation by the same measure at rest. These quantitative flow and flow reserve values were compared to clinically acquired gated studies in the 30 participants.
3-8 minute
Study Arms (1)
Hybrid PET/CT
EXPERIMENTALInterventions
Rest and vasodilation stress rubidium PET and coronary angiography with CT were performed using standard doses for clinically indicated studies.
Eligibility Criteria
You may qualify if:
- Subject must be 18 years of age or older and able to give informed consent.
- Scheduled for clinically indicated gated Adenoscan SPECT studies at the University of Maryland Medical Center or Baltimore VA Center
- Documentation from participant's health care provider indicating no objection to subject's participation in study.
You may not qualify if:
- Hepatic; thyroid or renal disease (creatinine \>1.5 or GFR \< 60mL/min)
- Women of childbearing age not using medically acceptable form of contraception, pregnant or breast-feeding
- Contrast allergy
- Inability to cooperate with imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Maryland, Baltimorelead
- Astellas Pharma Inccollaborator
Study Sites (1)
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
For rubidium PET, statistical noise in static or gated images and quantitative accuracy in early-phase dynamic images could not be simultaneously optimized on the hybrid PET/CT scanner.
Results Point of Contact
- Title
- Vasken Dilsizian, MD
- Organization
- University of Maryland, Baltimore
Study Officials
- PRINCIPAL INVESTIGATOR
Vasken Dilsizian, M.D.
University of Maryland, College Park
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 28, 2006
First Posted
May 3, 2006
Study Start
March 1, 2006
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
June 9, 2021
Results First Posted
June 9, 2021
Record last verified: 2021-05